PMID: 9164427Apr 1, 1997Paper

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study

The Journal of Clinical Psychiatry
I M van VlietK L Pian

Abstract

The results of open pilot studies suggest that the serotonin-1A (5-HT1A) receptor agonist buspirone might be effective in social phobia. In the present study, the efficacy of buspirone was investigated in patients with social phobia using a 12-week double-blind placebo-controlled design. Thirty social phobic patients (DSM-IV) were treated with either buspirone 30 mg daily or placebo. Efficacy of treatment was measured using the Social Phobia Scale (subscores anxiety and avoidance) and the Hamilton Rating Scale for Anxiety. Taking a reduction of 50% or more on the Social Phobia Scale as a criterion for clinically relevant improvement, only 1 patient on buspirone and 1 on placebo were classified as responder to treatment. A subjective and clinically relevant improvement was reported by 4 patients (27%) on buspirone and 2 patients (13%) on placebo. There were no statistically significant differences between buspirone and placebo on any of the outcome measures. Generally speaking, buspirone was well tolerated. The results of the study do not support the results of open studies, in which a reduction of social anxiety and social avoidance was reported in patients with social phobia treated with buspirone.

Citations

Oct 16, 2003·Pediatric Clinics of North America·Christopher K Varley, Cindy J Smith
Jan 13, 1999·Pediatric Clinics of North America·B BirmaherJ Renaud
May 5, 2001·Pharmacology & Therapeutics·S V ArgyropoulosD J Nutt
Aug 15, 2000·Journal of Affective Disorders·N BrunelloH U Wittchen
May 6, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Andreas BroocksB Bandelow
Dec 22, 1999·Biological Psychiatry·J C Ballenger
Oct 20, 2017·The Cochrane Database of Systematic Reviews·Taryn WilliamsDan J Stein
Aug 10, 1999·Journal of Clinical Psychopharmacology·A C PandeS M Sutherland
Jul 11, 2000·Journal of Psychopharmacology·J R Walker, K D Kjernisted
Nov 4, 2000·Expert Opinion on Investigational Drugs·M van AmeringenJ Oakman
Jan 9, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Borwin BandelowUNKNOWN World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·M Versiani
Jun 12, 2009·CNS Spectrums·Herman G M Westenberg
Mar 23, 2012·The International Journal of Neuropsychopharmacology·Carlos BlancoMichael R Liebowitz
Feb 6, 1999·Journal of Clinical Psychopharmacology·J T Apter, L A Allen
Oct 7, 1998·Acta Psychiatrica Scandinavica·A Stravynski, D Greenberg
Dec 21, 2000·Current Psychiatry Reports·M Van AmeringenJ Oakman
Oct 6, 2000·Acta Psychiatrica Scandinavica. Supplementum·J Zohar, H G Westenberg
Dec 20, 2002·International Clinical Psychopharmacology·Giuseppe MainaFilippo Bogetto
Oct 31, 2002·Human Psychopharmacology·Johan A. Den BoerBernhard R. Slaap
Feb 15, 2008·Expert Review of Neurotherapeutics·Jonathan C IpserDan J Stein
Aug 16, 2008·The Mount Sinai Journal of Medicine, New York·Ellen J Hoffman, Sanjay J Mathew
Aug 6, 2010·Current Psychiatry Reports·Dan J SteinMichael van Ameringen
Jan 19, 2011·Expert Opinion on Pharmacotherapy·Franklin R Schneier
Nov 14, 1997·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·M M Antony
Aug 6, 2003·Depression and Anxiety·Carlos BlancoMichael R Liebowitz
Feb 10, 2004·CNS Spectrums·Michael Van AmeringenUNKNOWN World Council of Anxiety
Oct 27, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Sabine C HerpertzUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP)
Jun 2, 2001·Journal of Clinical Psychopharmacology·I C Fedoroff, S Taylor
Sep 22, 2001·Journal of Psychopharmacology·D B OosterbaanR van Dyck
Oct 26, 1999·Epilepsia·K M ConnorR Weisler
Sep 3, 2003·Acta Psychiatrica Scandinavica. Supplementum·J R T Davidson
Apr 29, 2008·CNS Spectrums·C L Masia, F R Schneier
Oct 25, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Borwin BandelowJohann Vega
Aug 20, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O S Levin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Related Papers

The Journal of Clinical Psychiatry
M E Tancer, T W Uhde
Depression and Anxiety
H B SimpsonM R Liebowitz
The British Journal of Psychiatry : the Journal of Mental Science
F R SchneierM R Liebowitz
© 2021 Meta ULC. All rights reserved